Literature DB >> 8239156

Detection and correction of hypoxemia associated with air travel.

K P Vohra1, R A Klocke.   

Abstract

Hypoxemia occurs during air travel because the pressure in aircraft cabins is not maintained equal to barometric pressure at sea level. Identification of patients who will develop significant arterial hypoxemia is most conveniently achieved by exposing these individuals to inspired oxygen tensions similar to those experienced during air travel. We utilized commercial Venturi devices with nitrogen as a source gas to lower inspired oxygen tensions (114 and 99 mm Hg) to simulate exposure to altitude (6,700 and 10,000 feet) that occurs with air travel. Oxygen was administered by nasal cannulas to correct the induced hypoxemia. Eleven normal subjects had baseline oxygen saturations of 97.3% as determined by ear oximetry. Exposure to reduced oxygen tensions for 20 min using 35 and 40% Venturi devices caused minimal O2 desaturation (94.8 and 93.8%, respectively). Mean baseline arterial oxygen saturation was 93.2% in 11 patients with chronic obstructive lung disease. Oxygen saturation fell to 89.5 and 87.5%, respectively, with exposure to the two levels of reduced oxygen tensions. Hypoxemia was corrected with administration of O2 by nasal cannulas at rates of 1.2 and 1.5 L/min, respectively. We conclude that individual patients can be evaluated conveniently for possible development of hypoxemia associated with air travel using available Venturi devices. This approach also permits determination of the oxygen therapy needed to correct hypoxemia.

Entities:  

Mesh:

Year:  1993        PMID: 8239156     DOI: 10.1164/ajrccm/148.5.1215

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations.

Authors: 
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

2. 

Authors:  Francisco Ríos Tejada
Journal:  FMC       Date:  2009-01-06

Review 3.  Oxygen therapy in chronic obstructive pulmonary disease.

Authors:  Victor Kim; Joshua O Benditt; Robert A Wise; Amir Sharafkhaneh
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 4.  [Air travel and respiratory diseases].

Authors:  Francisco García Río; Luis Borderías Clau; Ciro Casanova Macario; Bartolomé R Celli; Joan Escarrabill Sanglás; Nicolás González Mangado; Josep Roca Torrent; Fernando Uresandi Romero
Journal:  Arch Bronconeumol       Date:  2007-02       Impact factor: 4.872

Review 5.  Chronic obstructive pulmonary disease * 11: fitness to fly with COPD.

Authors:  A O C Johnson
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

6.  A Protocol to Evaluate Retinal Vascular Response Using Optical Coherence Tomography Angiography.

Authors:  David Cordeiro Sousa; Inês Leal; Susana Moreira; Sónia do Vale; Ana S Silva-Herdade; Patrício Aguiar; Patrícia Dionísio; Luís Abegão Pinto; Miguel A R B Castanho; Carlos Marques-Neves
Journal:  Front Neurosci       Date:  2019-06-12       Impact factor: 4.677

7.  Health risks to air travelers.

Authors:  Muhammad R Sohail; Philip R Fischer
Journal:  Infect Dis Clin North Am       Date:  2005-03       Impact factor: 5.982

8.  Retinal Vascular Reactivity in Type 1 Diabetes Patients Without Retinopathy Using Optical Coherence Tomography Angiography.

Authors:  David Cordeiro Sousa; Inês Leal; Susana Moreira; Sónia do Vale; Ana S Silva-Herdade; Patrício Aguiar; Patrícia Dionísio; Luís Abegão Pinto; Miguel A R B Castanho; Carlos Marques-Neves
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

9.  BTS Clinical Statement on air travel for passengers with respiratory disease.

Authors:  Robina Kate Coker; Alison Armstrong; Alistair Colin Church; Steve Holmes; Jonathan Naylor; Katharine Pike; Peter Saunders; Kristofer John Spurling; Pamela Vaughn
Journal:  Thorax       Date:  2022-02-28       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.